Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB1 | P15086 | 1/20 | 0.62 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.62 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.61 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.61 |
| ▸ | SIRT2 | Q8IXJ6 | 7/20 | 0.60 |
| ▸ | SIRT1 | Q96EB6 | 5/20 | 0.60 |
| ▸ | SIRT3 | Q9NTG7 | 4/20 | 0.60 |
| ▸ | CTSL | P07711 | 1/20 | 0.59 |
| ▸ | CTSS | P25774 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14519212 | 1.00 | CPB1 (0.62) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL4360627 | 0.98 | CPB1 (0.60) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL16782306 | 0.94 | SIRT2 (0.66) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL8641871 | 0.90 | FOLH1 (0.69) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL14519208 | 0.90 | FOLH1 (0.69) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL20980386 | 0.89 | CPB1 (0.60) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL17889672 | 0.88 | SIRT5 (0.64) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL17889673 | 0.88 | SIRT5 (0.64) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL21345089 | 0.88 | CPB1 (0.57) | CPB1CPB2SIRT5FOLH1SIRT2 | |
| SCHEMBL21345094 | 0.88 | CPB1 (0.57) | CPB1CPB2SIRT5FOLH1SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7199268-B2 | Process for the production of dendritic trimesic acid triamides | SCHERING AKTIENGESELLSCHAFT (DE) | 2007-04-03 | — | — | US | disclosed |
| US-20050238615-A1 | Process for the production of dendritic trimesic acid triamides | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050238615-A1 | Process for the production of dendritic trimesic acid triamides | TRIM4, TRIM59, TRIM58 | CPB1 2293/4885CPB2 2362/4885SIRT5 1715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.